TY - JOUR
T1 - L'evoluzione da sindrome da anticorpi antifosfolipidi primaria a lupus eritematoso sistemico
T2 - Possono gli anticorpi anti-nucleosomi essere predittivi?
AU - Andreoli, Laura
AU - Pregnolato, F.
AU - Burlingame, R. W.
AU - Fanelli, V.
AU - Allegri, F.
AU - Radice, A.
AU - Corace, C.
AU - Sinico, R. A.
AU - Tincani, A.
AU - Meroni, P. L.
PY - 2008
Y1 - 2008
N2 - Objective: It was reported by several groups that patients diagnosed as primary antiphospholipid syndrome (PAPS) had developed a full-blown systemic lupus erythematosus (SLE) even after many years of follow-up. Little is known about clinical and/or serological factors that may help predict such evolution. Antinucleosome antibodies (anti-NCS) were described to appear in early stages of SLE, in particular before anti-dsDNA antibodies. The aim of the study is to evaluate the prevalence of anti-NCS in a large cohort of PAPS patients. Methods: IgG and IgM anti-NCS antibodies were detected using a home made assay with H1-stripped chromatin as antigen. Sera from 106 PAPS patients were tested; 52 of them were also tested during the follow-up, at least 2 years apart form the basal sample. Results: Medium-high titre anti-NCS were found in nearly half of the patients (49/106.46%), more frequently in those presenting features of "lupus like disease". Most of patients displayed an unchanged pattern of anti-NCS over time. We describe three cases of PAPS patients that developed SLE after many years of follow-up; high titre and low titre anti-NCS were present in two and one of them respectively several years before evolving into SLE. Conclusions: A significant proportion of PAPS patients displayed medium-high titre anti-NCS, suggesting that the autoimmune response against chromatin may be a relevant event not only in patients with SLE. Further studies are warranted to explore the predictive value of anti-NCS with respect to the evolution from PAPS to SLE.
AB - Objective: It was reported by several groups that patients diagnosed as primary antiphospholipid syndrome (PAPS) had developed a full-blown systemic lupus erythematosus (SLE) even after many years of follow-up. Little is known about clinical and/or serological factors that may help predict such evolution. Antinucleosome antibodies (anti-NCS) were described to appear in early stages of SLE, in particular before anti-dsDNA antibodies. The aim of the study is to evaluate the prevalence of anti-NCS in a large cohort of PAPS patients. Methods: IgG and IgM anti-NCS antibodies were detected using a home made assay with H1-stripped chromatin as antigen. Sera from 106 PAPS patients were tested; 52 of them were also tested during the follow-up, at least 2 years apart form the basal sample. Results: Medium-high titre anti-NCS were found in nearly half of the patients (49/106.46%), more frequently in those presenting features of "lupus like disease". Most of patients displayed an unchanged pattern of anti-NCS over time. We describe three cases of PAPS patients that developed SLE after many years of follow-up; high titre and low titre anti-NCS were present in two and one of them respectively several years before evolving into SLE. Conclusions: A significant proportion of PAPS patients displayed medium-high titre anti-NCS, suggesting that the autoimmune response against chromatin may be a relevant event not only in patients with SLE. Further studies are warranted to explore the predictive value of anti-NCS with respect to the evolution from PAPS to SLE.
KW - Antichromatin antibodies
KW - Antinucleosome antibodies
KW - Primary antiphospholipid syndrome
KW - Systemic lupus erythematosus
UR - http://www.scopus.com/inward/record.url?scp=57149134119&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=57149134119&partnerID=8YFLogxK
M3 - Articolo
C2 - 18854879
AN - SCOPUS:57149134119
VL - 60
SP - 185
EP - 191
JO - Reumatismo
JF - Reumatismo
SN - 0048-7449
IS - 3
ER -